Sofie Deschoemaeker
@sofiedeschoemaeker.bsky.social
Post-doctoral scientist @Laoui Team @VUB @VIBLifeSciences passionate about cancer immunology by day and travelling and good food by night :-)
Reposted by Sofie Deschoemaeker
The Laoui Lab will be well represented at the Tumor Heterogeneity, Plasticity and Therapy (3rd edition) conference #THPT25! Join us to hear more about therapy resistence in #cancer from Anna Obenauf
@obenaufa.bsky.social
Submit your abstract by the 8th of October on vibbio.tech/THPT25
@obenaufa.bsky.social
Submit your abstract by the 8th of October on vibbio.tech/THPT25
October 7, 2025 at 12:27 PM
The Laoui Lab will be well represented at the Tumor Heterogeneity, Plasticity and Therapy (3rd edition) conference #THPT25! Join us to hear more about therapy resistence in #cancer from Anna Obenauf
@obenaufa.bsky.social
Submit your abstract by the 8th of October on vibbio.tech/THPT25
@obenaufa.bsky.social
Submit your abstract by the 8th of October on vibbio.tech/THPT25
Glad to have been part of this exciting project!
🚨 New publication!
In a collaborative effort led by Etherna, we reveal how two optimized LNPs trigger distinct IgG2a vs IgG1 phenotypes.
This opens the door to tuning LNP design for tailored immune responses in mRNA vaccines & beyond.
advanced.onlinelibrary.wiley.com/doi/10.1002/...
In a collaborative effort led by Etherna, we reveal how two optimized LNPs trigger distinct IgG2a vs IgG1 phenotypes.
This opens the door to tuning LNP design for tailored immune responses in mRNA vaccines & beyond.
advanced.onlinelibrary.wiley.com/doi/10.1002/...
Next‐Generation Bio‐Reducible Lipids Enable Enhanced Vaccine Efficacy in Malaria and Primate Models
Structure–activity relationship (SAR) optimization of bio-reducible ionizable lipids enables the development of highly effective lipid nanoparticle (LNP) mRNA vaccines. Lead LNPs show superior tolera...
advanced.onlinelibrary.wiley.com
September 23, 2025 at 6:55 PM
Glad to have been part of this exciting project!
The coming 3 days, I’m conference reporter at the Immune Niches in Cancer and Inflammation conference in Bruges #INCI25 😀
Follow @laouimmunology.bsky.social, our lab accounts for the highlights!
Follow @laouimmunology.bsky.social, our lab accounts for the highlights!
After some lunch and the first poster session, we are ready for the afternoon session with my fellow conference reporters to report back on the most interesting talks at #INCI25.
So follow @tommasoscolaro.bsky.social and @vibtrainconf.bsky.social to learn about the newest hot topics!
So follow @tommasoscolaro.bsky.social and @vibtrainconf.bsky.social to learn about the newest hot topics!
May 7, 2025 at 4:18 PM
The coming 3 days, I’m conference reporter at the Immune Niches in Cancer and Inflammation conference in Bruges #INCI25 😀
Follow @laouimmunology.bsky.social, our lab accounts for the highlights!
Follow @laouimmunology.bsky.social, our lab accounts for the highlights!
April 8, 2025 at 4:30 PM
Reposted by Sofie Deschoemaeker
Interested in hearing more about how our 🕐internal clock🕐 can influence anti-tumor immunity? Christoph Scheiermann will explain all about it at the Immune Niches in Cancer and Inflammation conference #INCI25 !
Don’t miss the early bird registration!
🚨Deadline: 26th of March
vibbio.tech/INCI25
Don’t miss the early bird registration!
🚨Deadline: 26th of March
vibbio.tech/INCI25
March 21, 2025 at 3:44 PM
Interested in hearing more about how our 🕐internal clock🕐 can influence anti-tumor immunity? Christoph Scheiermann will explain all about it at the Immune Niches in Cancer and Inflammation conference #INCI25 !
Don’t miss the early bird registration!
🚨Deadline: 26th of March
vibbio.tech/INCI25
Don’t miss the early bird registration!
🚨Deadline: 26th of March
vibbio.tech/INCI25
Reposted by Sofie Deschoemaeker
🚨Early Bird registration deadline for #INCI25 is approaching
Register before the 26th of March and join us in Bruges to hear more from Miriam Merad on the regulation of #TLS formation and maintenance in #cancer and discuss the role of #DCs in TLS 😃
@miriammerad.bsky.social
vibbio.tech/INCI25
Register before the 26th of March and join us in Bruges to hear more from Miriam Merad on the regulation of #TLS formation and maintenance in #cancer and discuss the role of #DCs in TLS 😃
@miriammerad.bsky.social
vibbio.tech/INCI25
March 13, 2025 at 9:06 AM
🚨Early Bird registration deadline for #INCI25 is approaching
Register before the 26th of March and join us in Bruges to hear more from Miriam Merad on the regulation of #TLS formation and maintenance in #cancer and discuss the role of #DCs in TLS 😃
@miriammerad.bsky.social
vibbio.tech/INCI25
Register before the 26th of March and join us in Bruges to hear more from Miriam Merad on the regulation of #TLS formation and maintenance in #cancer and discuss the role of #DCs in TLS 😃
@miriammerad.bsky.social
vibbio.tech/INCI25
My abstract is submitted already, don't forget to submit yours to join us at #INCI25 in Bruges to discuss how dendritic cells can serve as cancer therapy 😀
At the #INCI25, a full session is dedicated to #celltherapy. As dendritic cell aficionados, we are excited to hear more about engineered dendritic cells from expert in the field Michele De Palma from EPFL!
Join us and submit your abstract!
Abstract deadline: 28th of February
vibbio.tech/INCI25
Join us and submit your abstract!
Abstract deadline: 28th of February
vibbio.tech/INCI25
February 25, 2025 at 5:58 PM
My abstract is submitted already, don't forget to submit yours to join us at #INCI25 in Bruges to discuss how dendritic cells can serve as cancer therapy 😀
Reposted by Sofie Deschoemaeker
⌛ Only three days left until the #INCI25 abstract deadline! Submit your #cancerbiology or #inflammation research by Friday, February 28.
Present your research on stage or in poster sessions to win the Cell Press Poster Prize🏆. Upload it to vibbio.tech/4gYySvZ
Present your research on stage or in poster sessions to win the Cell Press Poster Prize🏆. Upload it to vibbio.tech/4gYySvZ
February 25, 2025 at 2:20 PM
⌛ Only three days left until the #INCI25 abstract deadline! Submit your #cancerbiology or #inflammation research by Friday, February 28.
Present your research on stage or in poster sessions to win the Cell Press Poster Prize🏆. Upload it to vibbio.tech/4gYySvZ
Present your research on stage or in poster sessions to win the Cell Press Poster Prize🏆. Upload it to vibbio.tech/4gYySvZ
Join us and discover our research at #INCI25 in the wonderfull Bruges ! Submit your abstract by the 28th of February at vibbio.tech/INCI25
February 19, 2025 at 8:38 AM
Join us and discover our research at #INCI25 in the wonderfull Bruges ! Submit your abstract by the 28th of February at vibbio.tech/INCI25
Reposted by Sofie Deschoemaeker
Today is #womaninscience day! For all the ladies out there that doubt if science is something for them, yes it is! #proudoftheteam @vubrussel @viblifesciences.bsky.social
February 11, 2025 at 9:32 AM
Today is #womaninscience day! For all the ladies out there that doubt if science is something for them, yes it is! #proudoftheteam @vubrussel @viblifesciences.bsky.social
Reposted by Sofie Deschoemaeker
Excited to share our latest work in @NatureComms
! 🎉 LNP-formulated mRNA encoding IL-21, IL-7, & 4-1BB drives systemic anti-tumor immunity—spotlight on cDC2s! 👀 Led by Ahmed Hamouda, in collaboration with @eTheRNA_engine
& @bruno_de_geest. Read here: rdcu.be/d2zQ7
! 🎉 LNP-formulated mRNA encoding IL-21, IL-7, & 4-1BB drives systemic anti-tumor immunity—spotlight on cDC2s! 👀 Led by Ahmed Hamouda, in collaboration with @eTheRNA_engine
& @bruno_de_geest. Read here: rdcu.be/d2zQ7
Intratumoral delivery of lipid nanoparticle-formulated mRNA encoding IL-21, IL-7, and 4-1BBL induces systemic anti-tumor immunity
Nature Communications - Local delivery of mRNA-based immunotherapy represents an option for cancer therapy. Here the authors report that intratumoral delivery of lipid nanoparticle-formulated mRNA...
rdcu.be
January 18, 2025 at 9:16 AM
Excited to share our latest work in @NatureComms
! 🎉 LNP-formulated mRNA encoding IL-21, IL-7, & 4-1BB drives systemic anti-tumor immunity—spotlight on cDC2s! 👀 Led by Ahmed Hamouda, in collaboration with @eTheRNA_engine
& @bruno_de_geest. Read here: rdcu.be/d2zQ7
! 🎉 LNP-formulated mRNA encoding IL-21, IL-7, & 4-1BB drives systemic anti-tumor immunity—spotlight on cDC2s! 👀 Led by Ahmed Hamouda, in collaboration with @eTheRNA_engine
& @bruno_de_geest. Read here: rdcu.be/d2zQ7